overview of recent changes to the treatment landscape for her2-positive crc
Published 4 months ago • 72 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
0:43
how will the mountaineer trial affect the her2-positive mcrc treatment landscape?
-
36:12
her2-positive metastatic colorectal cancer: unraveling game-changing treatment approaches
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
1:24
tucatinib and trastuzumab in the treatment paradigm of her2-positive mcrc
-
2:23
dr. john strickler on her2-positive colorectal cancer treatment advances | asco 2024
-
1:14
updated analysis from mountaineer: tucatinib and trastuzumab for her2-positive mcrc
-
13:38
breast cancer recurrence prevention - an illustrative tutorial from oster oncology
-
3:11
her2-positive breast cancer - how does it work? a doctor explains with simple images.
-
13:09
get all the info you need about her2 ve breast cancer - her2 ve breast cancer || dr liz o'riordan
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
24:05
what's new in colorectal cancer treatment? by michael hall, md, ms
-
1:08
targeting her2 in colorectal cancer
-
1:18:52
her2-positive gastrointestinal cancers: new evidence and practical guidance with targeted agents
-
6:29
evolving treatment landscape of r/r her2 mbc
-
0:55
phase 3 paradigm trial review | anwaar saaeed, md | asco22 colorectal cancer updates
-
1:04:45
her2 testing in metastaticcolorectal cancer (mcrc)
-
1:03:11
new advances in crc treatments: a global overview
-
2:06
updates in colorectal cancer research from esmo wcgic 2022
-
34:27
fulfilling the potential of her2-targeting in colorectal cancer: update on detection and management
-
3:09
her2 in cancer
-
1:35
dr. eng on the treatment landscape in metastatic colorectal cancer
-
2:29
mountaineer: tucatinib plus trastuzumab for her2 metastatic colorectal cancer